Drug News
-
Physician Fined and License Restricted for Improper Ivermectin Prescriptions and COVID-19 Misinformation
The Washington Medical Commission has taken disciplinary action against Dr. Richard Wilkinson, a physician who had been prescribing ivermectin to…
Read More » -
GSK’s Malaria Vaccine Combined with Drugs Shows Over 90% Reduction in Cases
The final results of a groundbreaking study that evaluated the effectiveness of GSK’s Mosquirix malaria vaccine in combination with antimalarial…
Read More » -
New Guidelines Suggest Safer Alternatives to Opioids for Kids’ Dental Pain
New guidelines suggest that children experiencing short-term dental pain from tooth extractions or toothaches should avoid being prescribed opioids. Instead,…
Read More » -
Promising Trial Results: Wegovy Shows Potential in Alleviating Heart Failure Symptoms
Wegovy (semaglutide), a groundbreaking weight-loss drug, has been in the spotlight for its transformative impact on obesity and diabetes treatment.…
Read More » -
CVS Health Ventures into Biosimilars Market with Cordavis: Disrupting Drug Costs and Accessibility
CVS Health has taken a decisive step in the realm of US biosimilars by introducing Cordavis, a novel business unit…
Read More » -
Evaluating the Impact and Challenges of the Innovative Medicines Fund (IMF)
The Innovative Medicines Fund (IMF), introduced in 2022 as a companion to the Cancer Drugs Fund (CDF), has sparked discussions…
Read More » -
X-raying The First Biosimilar to Tysabri for Multiple Sclerosis and Crohn’s Disease Approved By The FDA
In a significant stride for medical advancements, the U.S. Food and Drug Administration (FDA) has granted approval to Tyruko (natalizumab-sztn),…
Read More » -
High Costs and Profits: Ozempic’s Impact on U.S. Healthcare
The pharmaceutical landscape in the United States is experiencing a contentious twist as Type 2 diabetes drug Ozempic and weight…
Read More » -
Meet The Top 10 Experts At Google Health
Google Health, a division of tech giant Google, has been making waves in the healthcare industry with its innovative approaches…
Read More » -
Unfavorable FDA Panel Vote Impacts Medtronic’s Blood Pressure Device Fate
The U.S. Food and Drug Administration (FDA) expert panel has voted against the approval of Medtronic’s blood pressure treatment device,…
Read More »
